Medizinische Fachkraft
Bitte melden Sie sich an, um exklusive Informationen und Services zu erhalten.

Press Releases

Explore the newest and archived press releases about AOP Orphan, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via publicaffairs@aoporphan.com 

AOP Orphan Statement zu SARS-CoV-2 und COVID-19

17. 3. 2020

AOP Orphan will distribute Wakix® (pitolisant) from Bioprojet Pharma SAS in Austria, Nordic countries and Central Eastern Europe

22. 3. 2018

The Medical University of Innsbruck: Christian Doppler Laboratory for Iron Metabolism and Anemia Research is opened.

5. 2. 2018

AOP Orphan Pharmaceuticals AG to acquire Selisistat a clinical stage drug candidate for the treatment of Huntington’s disease (HD)

2. 10. 2017

AOP Orphan strengthens core CNS specialty business with high promise in movement disorder treatments

19. 6. 2015

Innovative antipsychotic ADASUVE® to benefit even more patients

27. 5. 2015

Stories

Narcolepsy Awareness Day, Sep 22, 2020

Narcolepsy is a rare lifelong neurological disorder that affects the natural cycles of sleeping and waking. It is characterized by excessive sleepiness during the day. This rare disease affects 2–5 out of every 10,000 people. No cure of the disease is currently possible. Therefore the treatment concentrates on relieving the symptoms as far as possible.

Huntington’s Disease Awareness May, 2020

"If you get diagnosed do not hide your head in the sand. Stay open, positive and keep up the hope for a cure. It is important to go on with regular life as long as possible, for example to continue working, meeting friends and family, having hobbies! Such non-medical treatments as regular exercising, physiotherapy, logotherapy and massage etc also have a positive impact!"

PH Awareness Day May 5, 2020

Univ. Prof. Irene Lang, MD

"The time taken to establish the correct diagnosis of chronic thromboembolic pulmonary hypertension is on average about 14 months. However, the disease process starts much earlier - at a time when nobody has any idea about pulmonary hypertension. I know of one case that took 30 years to turn into a manifested disease!"

MPN Awareness Day on Sep 12, 2019

Prof. Dr. Martin Griesshammer Director, Department of Hematology, Oncology, Hemostaseology and Palliative Medicine, Mühlenkreis clinics

"MPNs is a chronic haematological disease group caused by a stem-cell disorder."

Photos and Infographs

  • Infograph: Integrated care for rare diseases
    Bridging the gap to improve the lives of 30 million people in Europe.
    Infograph: Juggling care and daily life
    The balancing act of the rare disease community.
    Rare diseases seriously impact everyday life.

AOP Orphan Logo 

Contact

We believe that open communication is essential – not just in our day-to-day contact with business associates, but also with prospective partners, media, interested parties who are not yet familiar with AOP Orphan. We will be pleased to answer any questions you may have about the company, its products, studies, pipeline and overall plans.

Press contact

Lena Weissenbacher, BA
Corporate Communication Coordinator
+43 1 503 72 44 0
publicaffairs@aoporphan.com